Dracen Pharmaceuticals (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- March 23, 2018
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $40,000,000
Company Info
- Founders
- Barbara Slusher, Jonathan Powell, Rana Rais, Pavel Majer
- Company Description
- Dracen Pharmaceuticals is a developer of novel glutamine antagonists created to deliver improved outcomes for cancer patients.
- Market
- Cancer and autoimmune/inflammatory diseases
- Location
- Baltimore, MD, US
- Coinvestors
- Deerfield Management Company, L.P.